Chk2 Suppresses the Oncogenic Potential of DNA Replication-Associated DNA Damage (DOI:10.1016/j.molcel.2008.04.028);Chk2 Suppresses the Oncogenic Potential of DNA Replication-Associated DNA Damage

Molecular Cell

Volumn 31, Issue 1, 2008, Pages 21-32

  Stracker, Travis H ^a   Couto, Suzana S ^a   Cordon Cardo, Carlos ^a   Matos, Tulio ^a   Petrini, John H J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

CELLCYCLE; SIGNALING

Indexed keywords

CHECKPOINT KINASE 2; DNA; MRE11 PROTEIN; MUTANT PROTEIN; NIBRIN; PROTEIN P53; RAD50 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CHROMOSOMAL INSTABILITY; CHROMOSOME BREAKAGE; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EMBRYO FIBROBLAST; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME MECHANISM; FIBROBLAST; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; REGULATORY MECHANISM;

MUS;

EID: 46149124528     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2008.12.011     Document Type: Erratum

References (70)

1. Ahn J.Y., Schwarz J.K., Piwnica-Worms H., and Canman C.E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60 (2000) 5934-5936
2. Allen J.B., Zhou Z., Siede W., Friedberg E.C., and Elledge S.J. The SAD1/RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast. Genes Dev. 8 (1994) 2401-2415
3. *1100delC promotes genomic instability in a knock-in mouse model. Mutat. Res. 616 (2007) 201-209
4. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
5. Barboza J.A., Liu G., Ju Z., El-Naggar A.K., and Lozano G. p21 delays tumor onset by preservation of chromosomal stability. Proc. Natl. Acad. Sci. USA 103 (2006) 19842-19847
6. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86 (1996) 159-171
7. Barlow C., Brown K.D., Deng C.X., Tagle D.A., and Wynshaw-Boris A. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat. Genet. 17 (1997) 453-456
8. Bartek J., Falck J., and Lukas J. CHK2 kinase-a busy messenger. Nat. Rev. Mol. Cell Biol. 2 (2001) 877-886
9. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
10. Bassing C.H., and Alt F.W. The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst.) 3 (2004) 781-796
11. Boddy M.N., Furnari B., Mondesert O., and Russell P. Replication checkpoint enforced by kinases Cds1 and Chk1. Science 280 (1998) 909-912
12. Boulton S.J. Cellular functions of the BRCA tumour-suppressor proteins. Biochem. Soc. Trans. 34 (2006) 633-645
13. Bressan D.A., Baxter B.K., and Petrini J.H. The Mre11-Rad50-Xrs2 protein complex facilitates homologous recombination-based double-strand break repair in Saccharomyces cerevisiae. Mol. Cell. Biol. 19 (1999) 7681-7687
14. Cao L., Kim S., Xiao C., Wang R.H., Coumoul X., Wang X., Li W.M., Xu X.L., De Soto J.A., Takai H., et al. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J. 25 (2006) 2167-2177
15. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., and Weitzman M.D. The Mre11 complex is required for ATM activation and the G(2)/M checkpoint. EMBO J. 22 (2003) 6610-6620
16. Chao C., Herr D., Chun J., and Xu Y. Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. EMBO J. 25 (2006) 2615-2622
17. Chehab N.H., Malikzay A., Appel M., and Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14 (2000) 278-288
18. Donehower L.A., Harvey M., Slagle B.L., Mc Arthur M.J., Montgomery C.A.J., Butel J.S., and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaenous tumours. Nature 356 (1992) 215-221
19. Falck J., Mailand N., Syljuasen R.G., Bartek J., and Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410 (2001) 842-847
20. Falck J., Petrini J.H., Williams B.R., Lukas J., and Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet. 30 (2002) 290-294
21. Falck J., Coates J., and Jackson S.P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434 (2005) 605-611
22. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95 (1998) 891-902
23. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio Jr. R.A., Kastrinakis N.G., Levy B., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
24. Guidos C.J., Williams C.J., Grandal I., Knowles G., Huang M.T.F., and Danska J.S. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocytes. Genes Dev. 10 (1996) 2038-2054
25. Herzog K.H., Chong M.J., Kapsetaki M., Morgan J.I., and McKinnon P.J. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280 (1998) 1089-1091
26. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., and Mak T.W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287 (2000) 1824-1827
27. Hirao A., Cheung A., Duncan G., Girard P.M., Elia A.J., Wakeham A., Okada H., Sarkissian T., Wong J.A., Sakai T., et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol. Cell. Biol. 22 (2002) 6521-6532
28. Jack M.T., Woo R.A., Hirao A., Cheung A., Mak T.W., and Lee P.W. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response. Proc. Natl. Acad. Sci. USA 99 (2002) 9825-9829
29. Jallepalli P.V., Lengauer C., Vogelstein B., and Bunz F. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278 (2003) 20475-20479
30. Kastan M.B., Zhan Q., El-Diery W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., and Fornace A.J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71 (1992) 587-597
31. Kitagawa R., Bakkenist C.J., McKinnon P.J., and Kastan M.B. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev. 18 (2004) 1423-1438
32. Kuerbitz S.J., Plunkett B.S., Walsh W.V., and Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89 (1992) 7491-7495
33. Kwak E.L., Kim S., Zhang J., Cardiff R.D., Schmidt E.V., and Haber D.A. Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant. Cancer Res. 66 (2006) 1923-1928
34. Lee J.H., and Paull T.T. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26 (2007) 7741-7748
35. Li J., and Stern D.F. Regulation of CHK2 by DNA-dependent protein kinase. J. Biol. Chem. 280 (2005) 12041-12050
36. Lin W.C., and Desiderio S. V(D)J recombination and the cell cycle. Immunol. Today 16 (1995) 279-289
37. Lindsay H.D., Griffiths D.J., Edwards R.J., Christensen P.U., Murray J.M., Osman F., Walworth N., and Carr A.M. S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe. Genes Dev. 12 (1998) 382-395
38. Liu G., Parant J.M., Lang G., Chau P., Chavez-Reyes A., El-Naggar A.K., Multani A., Chang S., and Lozano G. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat. Genet. 36 (2004) 63-68
39. MacPherson D., Kim J., Kim T., Rhee B.K., Van Oostrom C.T., DiTullio R.A., Venere M., Halazonetis T.D., Bronson R., De Vries A., et al. Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. EMBO J. 23 (2004) 3689-3699
40. Matsuoka S., Huang M., and Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282 (1998) 1893-1897
41. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., and Elledge S.J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97 (2000) 10389-10394
42. McPherson J.P., Lemmers B., Hirao A., Hakem A., Abraham J., Migon E., Matysiak-Zablocki E., Tamblyn L., Sanchez-Sweatman O., Khokha R., et al. Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev. 18 (2004) 1144-1153
43. Melchionna R., Chen X.B., Blasina A., and McGowan C.H. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat. Cell Biol. 2 (2000) 762-765
44. Morales M., Theunissen J.W., Kim C.F., Kitagawa R., Kastan M.B., and Petrini J.H. The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor. Genes Dev. 19 (2005) 3043-3054
45. Nacht M., Strasser A., Chan Y.R., Harris A.W., Schlissel S., Bronson R.T., and Jacks T. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10 (1996) 2055-2066
46. Nevanlinna H., and Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25 (2006) 5912-5919
47. Paulovich A.G., and Hartwell L.H. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell 82 (1995) 841-847
48. Petrini J.H., and Stracker T.H. The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol. 13 (2003) 458-462
49. Petrini J.H., and Theunissen J.W. Double strand break metabolism and cancer susceptibility: lessons from the Mre11 complex. Cell Cycle 3 (2004) 541-542
50. Powers J.T., Hong S., Mayhew C.N., Rogers P.M., Knudsen E.S., and Johnson D.G. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol. Cancer Res. 2 (2004) 203-214
51. Pusapati R.V., Rounbehler R.J., Hong S., Powers J.T., Yan M., Kiguchi K., McArthur M.J., Wong P.K., and Johnson D.G. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proc. Natl. Acad. Sci. USA 103 (2006) 1446-1451
52. Rogoff H.A., Pickering M.T., Frame F.M., Debatis M.E., Sanchez Y., Jones S., and Kowalik T.F. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol. Cell. Biol. 24 (2004) 2968-2977
53. Rooney S., Sekiguchi J., Whitlow S., Eckersdorff M., Manis J.P., Lee C., Ferguson D.O., and Alt F.W. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc. Natl. Acad. Sci. USA 101 (2004) 2410-2415
54. Roth D.B., Menetski J.P., Nakajima P.B., Bosma M.J., and Gellert M. V(D)J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell 70 (1992) 983-991
55. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3 (2003) 155-168
56. Soussi T., and Wiman K.G. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12 (2007) 303-312
57. Stracker T.H., Theunissen J.W., Morales M., and Petrini J.H. The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. DNA Repair (Amst.) 3 (2004) 845-854
58. Stracker T.H., Morales M., Couto S.S., Hussein H., and Petrini J.H. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature 447 (2007) 218-221 10.1038/nature05740 Published online April 11, 2007
59. Takai H., Naka K., Okada Y., Watanabe M., Harada N., Saito S., Anderson C.W., Appella E., Nakanishi M., Suzuki H., et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J. 21 (2002) 5195-5205
60. Theunissen J.W., and Petrini J.H. Methods for studying the cellular response to DNA damage: influence of the Mre11 complex on chromosome metabolism. Methods Enzymol. 409 (2006) 251-284
61. Theunissen J.W., Kaplan M.I., Hunt P.A., Williams B.R., Ferguson D.O., Alt F.W., and Petrini J.H. Checkpoint failure and chromosomal instability without lymphomagenesis in Mre11(ATLD1/ATLD1) mice. Mol. Cell 12 (2003) 1511-1523
62. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., and Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22 (2003) 5612-5621
63. Wang X.Q., Redpath J.L., Fan S.T., and Stanbridge E.J. ATR dependent activation of Chk2. J. Cell. Physiol. 208 (2006) 613-619
64. Westphal C.H., Rowan S., Schmaltz C., Elson A., Fisher D.E., and Leder P. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat. Genet. 16 (1997) 397-401
65. Williams B.R., Mirzoeva O.K., Morgan W.F., Lin J., Dunnick W., and Petrini J.H. A murine model of nijmegen breakage syndrome. Curr. Biol. 12 (2002) 648-653
66. Xu Y., and Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10 (1996) 2401-2410
67. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., and Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10 (1996) 2411-2422
68. -/- mice. Mol. Cell. Biol. 18 (1998) 4385-4390
69. You Z., Chahwan C., Bailis J., Hunter T., and Russell P. ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1. Mol. Cell. Biol. 25 (2005) 5363-5379
70. Zheng P., Fay D.S., Burton J., Xiao H., Pinkham J.L., and Stern D.F. SPK1 is an essential S-phase-specific gene of Saccharomyces cerevisiae that encodes a nuclear serine/threonine/tyrosine kinase. Mol. Cell. Biol. 13 (1993) 5829-5842